“Dose of Reality” Breaking Down the Big Pharma Dollar
May 16, 2019
Part II: An Industry Booming Off of Price-Gouging The average American spends… Read More
© 2024 CSRXP- All Rights Reserved
Updates
CSRxP Encourages U.S. House of Representatives to Pass Bipartisan CREATES Act
May 16, 2019
Commends Lawmakers of Both Parties for Working Together to Advance Key Drug… Read More
“Dose of Reality” Breaking Down the Big Pharma Dollar
May 15, 2019
Part I: The Math Undercuts the R&D Defense The average American spends… Read More
CSRxP Applauds Bipartisan Bill To Strengthen Drug Pricing Transparency
May 14, 2019
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today… Read More
CSRxP Study Confirms: Big Pharma Invests Boldly in Profits and Advertising — Not R&D
May 14, 2019
Analysis Finds Industry Spending on Advertising, Overhead and Profits More… Read More
CSRxP Praises FDA For Finalizing Guidance On Interchangeable Biologics
May 10, 2019
Clearer Guidelines Will Increase Choice and Help Lower Prices Washington… Read More
THEY SAID IT! House Energy & Commerce Lawmakers Roast Big Pharma, Pledge Bipartisan Action and Question the Rebate Rule
May 10, 2019
Washington, D.C. – The House Energy & Commerce Subcommittee on Health… Read More
CSRxP: Congress Takes First Step On Drug Pricing, Now Lawmakers Must Deliver
May 8, 2019
Encourages House Leaders To Keep The Momentum Going Following Passage Of First… Read More
CSRxP Urges House Lawmakers to Pass First Drug Pricing Bills of the Year
May 8, 2019
Vote On Orange And Purple Book Bills Should Mark Beginning Of A Series Of… Read More
CSRxP Praises Administration For Implementing Direct-To-Consumer Advertising Rule
May 8, 2019
Greater List Price Transparency Will Help Hold Big Pharma Accountable … Read More
CSRxP: Senate Judiciary Lawmakers Grill Big Pharma, Demonstrate Bipartisan Commitment To Action
May 7, 2019
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today… Read More
CSRxP Welcomes Senate Scrutiny Of Big Pharma’s Patent Abuse
May 6, 2019
Encourages Judiciary Committee To Hold Drug Makers Accountable… Read More